Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

被引:70
作者
Morecki, S [1 ]
Gelfand, Y [1 ]
Nagler, A [1 ]
Or, R [1 ]
Naparstek, E [1 ]
Varadi, G [1 ]
Engelhard, D [1 ]
Akerstein, A [1 ]
Slavin, S [1 ]
机构
[1] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel
关键词
immune response; allogeneic bone marrow transplantation (BMT); non-myeloablative stein cell transplantation; (NST);
D O I
10.1038/sj.bmt.1703118
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We have investigated the immune status of patients with hematologic malignancies treated with a low intensity conditioning in preparation for allogeneic stem cell transplantation. Conditioning consisted of fludarabine, anti-T lymphocyte globulin and low-dose busulfan, followed by infusion of allogeneic blood stem cells. This protocol resulted in rapid engraftment and complete replacement of host with donor hematopoietic cells. Immunological parameters of these patients were compared to those patients who were conditioned by an aggressive myeloablative regimen. Distribution of cell surface markers of lymphocyte subsets from both groups of patients was similar, but different from that of normal control cells. Reduced intensity or non-myeloablative conditioning prior to allogeneic stein cell transplantation (NST), hardly lowered the normal T cell-dependent mitogenic response even during the early period following transplant, while the myeloablative treatments resulted in a suppressed mitogenic reaction and in slow immune recovery. Reactivity of non-MHC restricted cytotoxic T cells was also at a normal level in patients who were treated with NST. We conclude that stem cell engraftment following reduced conditioning may result in early reconstitution of immune responses assessed in vitro. We hypothesize that clinical application of NST may lead to faster development of effective immune responses against residual host-type malignant and abnormal non-malignant hematopoietic cells, although the role of fludarabine on post-transplant infections remains to be investigated in a larger cohort of patients.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 42 条
[1]   B-LYMPHOCYTE REGENERATION IN MARROW AND BLOOD AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - INCREASED NUMBERS OF B-CELLS CARRYING ACTIVATION AND PROGRESSION MARKERS [J].
BENGTSSON, M ;
SMEDMYR, B ;
FESTIN, R ;
OBERG, G ;
SIMONSSON, B ;
TOTTERMAN, TH .
LEUKEMIA RESEARCH, 1989, 13 (09) :791-797
[2]  
Boyum A., 1968, SCAND J CLIN LAB INV, V21, P97
[3]  
CHAN EYT, 1994, ASIAN PAC J ALLERGY, V12, P117
[4]  
COMOLI P, 1994, CLIN EXP IMMUNOL, V97, P510
[5]  
FOOT ABM, 1993, BONE MARROW TRANSPL, V11, P7
[6]   Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy [J].
Giralt, S ;
Estey, E ;
Albitar, M ;
vanBesien, K ;
Rondon, G ;
Anderlini, P ;
OBrien, S ;
Khouri, I ;
Gajewski, J ;
Mehra, R ;
Claxton, D ;
Andersson, B ;
Beran, M ;
Przepiorka, D ;
Koller, C ;
Kornblau, S ;
Korbling, M ;
Keating, M ;
Kantarjian, H ;
Champlin, R .
BLOOD, 1997, 89 (12) :4531-4536
[7]  
HOROWITZ MM, 1990, BLOOD, V75, P555
[8]   RECONSTITUTION WITH SYNGENEIC PLUS ALLOGENEIC OR XENOGENEIC BONE-MARROW LEADS TO SPECIFIC ACCEPTANCE OF ALLOGRAFTS OR XENOGRAFTS [J].
ILDSTAD, ST ;
SACHS, DH .
NATURE, 1984, 307 (5947) :168-170
[9]  
Johnson S, 1996, Lancet, V347, P1432
[10]   DIFFERENTIAL CD26-MEDIATED ACTIVATION OF THE CD3 AND CD2 PATHWAYS AFTER CD6-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
KAMEOKA, J ;
SATO, T ;
TORIMOTO, Y ;
SUGITA, K ;
SOIFFER, RJ ;
SCHLOSSMAN, SF ;
RITZ, J ;
MORIMOTO, C .
BLOOD, 1995, 85 (04) :1132-1137